~~<i id='DDD8CB0141'><strike id='DDD8CB0141'><tt id='DDD8CB0141'><pre id='DDD8CB0141'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

fashion

author：focus 2025-09-29 09:29:41 - browse：27

Three sales executives, all of them women, have filed suit against Grail, a cancer diagnostics company, alleging that they were harassed, that the company failed to take corrective action, and that it retaliated by removing them from consideration for promotions.

The suits, which were filed earlier this week, are complicated by the fact that Grail was purchased by Illumina, the largest DNA sequencing firm, for $8 billion in 2021 — yet Illumina has left Grail to operate as a separate company. Illumina is named in the suit.

All three plaintiffs are being represented by the Vora Law Firm, based in Santa Monica, Calif.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： STAT Boddities: What happens to the brain when we get scared?

entertainment

focus

hotspot

explore

CDCWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechnewsletterinyour

WSS

Trump demands the U.S. pay no more for drugs than other countries … again

Resistance to opioid

The high cost of giving birth even with insurance

Dobbs anniversary: the lost opportunity of abortion as health care

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

In age of alternative facts, a scholarly course on calling out crap

explore

fashion

entertainment

Psychedelics group wrestles with new pharma identity

Report cites 'urgent' need to recruit more diverse clinical trial participants

Dobbs anniversary: the lost opportunity of abortion as health care

Tori Bowie and the unacceptable rates of Black maternal death

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Report cites 'urgent' need to recruit more diverse clinical trial participants

Medical leaders decry Supreme Court decision on affirmative action

Report cites 'urgent' need to recruit more diverse clinical trial participants

FDA approval of Sarepta Duchenne genetic therapy gives me hope

George Santos makes 1st court appearance after pleading not guilty to 13 counts

focus

Virginia high school admissions case could be legal follow

DIEP, the 'gold standard' of breast reconstruction, is under threat

Study gives hint on South Asians’ higher risk of cardiovascular disease

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Novavax promises a turnaround & Lilly roils the obesity market

Congress must protect the remaining independent doctors

focus

hotspot

hotspot

explore